nodes	percent_of_prediction	percent_of_DWPC	metapath
Benazepril—MTHFR—Fluorouracil—skin cancer	0.672	1	CbGbCtD
Benazepril—ACE—forelimb zeugopod—skin cancer	0.0203	0.175	CbGeAlD
Benazepril—ACE—forelimb—skin cancer	0.0102	0.0879	CbGeAlD
Benazepril—ACE—hindlimb—skin cancer	0.00918	0.0791	CbGeAlD
Benazepril—ACE—arm—skin cancer	0.00877	0.0755	CbGeAlD
Benazepril—ACE—appendage—skin cancer	0.00787	0.0679	CbGeAlD
Benazepril—MTHFR—blood vessel—skin cancer	0.00718	0.0618	CbGeAlD
Benazepril—ACE—nerve—skin cancer	0.00558	0.0481	CbGeAlD
Benazepril—MTHFR—neck—skin cancer	0.00513	0.0442	CbGeAlD
Benazepril—ACE—endothelium—skin cancer	0.00475	0.041	CbGeAlD
Benazepril—ACE—blood vessel—skin cancer	0.00438	0.0378	CbGeAlD
Benazepril—ACE—neck—skin cancer	0.00314	0.027	CbGeAlD
Benazepril—SLC15A1—epithelium—skin cancer	0.00298	0.0256	CbGeAlD
Benazepril—MTHFR—lymphoid tissue—skin cancer	0.00269	0.0232	CbGeAlD
Benazepril—MTHFR—female reproductive system—skin cancer	0.00259	0.0224	CbGeAlD
Benazepril—SLC15A1—mammalian vulva—skin cancer	0.00258	0.0222	CbGeAlD
Benazepril—ACE—connective tissue—skin cancer	0.00225	0.0194	CbGeAlD
Benazepril—MTHFR—head—skin cancer	0.00217	0.0187	CbGeAlD
Benazepril—ACE—epithelium—skin cancer	0.00213	0.0184	CbGeAlD
Benazepril—ACE—mammalian vulva—skin cancer	0.00185	0.0159	CbGeAlD
Benazepril—ACE—lymphoid tissue—skin cancer	0.00164	0.0142	CbGeAlD
Benazepril—ACE—female reproductive system—skin cancer	0.00159	0.0137	CbGeAlD
Benazepril—MTHFR—lymph node—skin cancer	0.00152	0.0131	CbGeAlD
Benazepril—SLC15A2—female reproductive system—skin cancer	0.00138	0.0119	CbGeAlD
Benazepril—ACE—head—skin cancer	0.00132	0.0114	CbGeAlD
Benazepril—SLC15A2—head—skin cancer	0.00115	0.00995	CbGeAlD
Benazepril—Rhinitis—Imiquimod—skin cancer	0.00113	0.00534	CcSEcCtD
Benazepril—Pharyngitis—Imiquimod—skin cancer	0.00112	0.00528	CcSEcCtD
Benazepril—Back pain—Vemurafenib—skin cancer	0.00111	0.00526	CcSEcCtD
Benazepril—Asthenia—Vismodegib—skin cancer	0.00109	0.00515	CcSEcCtD
Benazepril—Pruritus—Vismodegib—skin cancer	0.00107	0.00508	CcSEcCtD
Benazepril—Erythema multiforme—Imiquimod—skin cancer	0.00106	0.00503	CcSEcCtD
Benazepril—Tinnitus—Imiquimod—skin cancer	0.00105	0.00496	CcSEcCtD
Benazepril—Flushing—Imiquimod—skin cancer	0.00104	0.00494	CcSEcCtD
Benazepril—Diarrhoea—Vismodegib—skin cancer	0.00104	0.00491	CcSEcCtD
Benazepril—Photosensitivity—Fluorouracil—skin cancer	0.00102	0.00484	CcSEcCtD
Benazepril—Arrhythmia—Imiquimod—skin cancer	0.00101	0.00476	CcSEcCtD
Benazepril—Cough—Vemurafenib—skin cancer	0.001	0.00474	CcSEcCtD
Benazepril—Alopecia—Imiquimod—skin cancer	0.000995	0.0047	CcSEcCtD
Benazepril—Myalgia—Vemurafenib—skin cancer	0.000978	0.00463	CcSEcCtD
Benazepril—Arthralgia—Vemurafenib—skin cancer	0.000978	0.00463	CcSEcCtD
Benazepril—Vomiting—Vismodegib—skin cancer	0.000965	0.00456	CcSEcCtD
Benazepril—Rash—Vismodegib—skin cancer	0.000957	0.00453	CcSEcCtD
Benazepril—Dermatitis—Vismodegib—skin cancer	0.000956	0.00452	CcSEcCtD
Benazepril—Back pain—Imiquimod—skin cancer	0.000948	0.00448	CcSEcCtD
Benazepril—Face oedema—Temozolomide—skin cancer	0.000941	0.00445	CcSEcCtD
Benazepril—Anaphylactic shock—Vemurafenib—skin cancer	0.000938	0.00443	CcSEcCtD
Benazepril—Infection—Vemurafenib—skin cancer	0.000932	0.00441	CcSEcCtD
Benazepril—ACE—lymph node—skin cancer	0.000927	0.00799	CbGeAlD
Benazepril—Nausea—Vismodegib—skin cancer	0.000902	0.00426	CcSEcCtD
Benazepril—Angioedema—Imiquimod—skin cancer	0.000895	0.00423	CcSEcCtD
Benazepril—Syncope—Imiquimod—skin cancer	0.000879	0.00416	CcSEcCtD
Benazepril—Acute coronary syndrome—Bleomycin—skin cancer	0.000878	0.00415	CcSEcCtD
Benazepril—Hypotension—Vemurafenib—skin cancer	0.000876	0.00414	CcSEcCtD
Benazepril—Myocardial infarction—Bleomycin—skin cancer	0.000873	0.00413	CcSEcCtD
Benazepril—Neutropenia—Dactinomycin—skin cancer	0.000871	0.00412	CcSEcCtD
Benazepril—Palpitations—Imiquimod—skin cancer	0.000866	0.0041	CcSEcCtD
Benazepril—Loss of consciousness—Imiquimod—skin cancer	0.000861	0.00407	CcSEcCtD
Benazepril—Cough—Imiquimod—skin cancer	0.000855	0.00404	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000854	0.00404	CcSEcCtD
Benazepril—Chest pain—Imiquimod—skin cancer	0.000834	0.00395	CcSEcCtD
Benazepril—Myalgia—Imiquimod—skin cancer	0.000834	0.00395	CcSEcCtD
Benazepril—Arthralgia—Imiquimod—skin cancer	0.000834	0.00395	CcSEcCtD
Benazepril—Anxiety—Imiquimod—skin cancer	0.000831	0.00393	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000824	0.0039	CcSEcCtD
Benazepril—Bronchitis—Temozolomide—skin cancer	0.000811	0.00383	CcSEcCtD
Benazepril—SLC15A2—lymph node—skin cancer	0.000809	0.00697	CbGeAlD
Benazepril—Fatigue—Vemurafenib—skin cancer	0.000809	0.00382	CcSEcCtD
Benazepril—Constipation—Vemurafenib—skin cancer	0.000802	0.00379	CcSEcCtD
Benazepril—Oedema—Imiquimod—skin cancer	0.0008	0.00378	CcSEcCtD
Benazepril—Infection—Imiquimod—skin cancer	0.000795	0.00376	CcSEcCtD
Benazepril—Neutropenia—Temozolomide—skin cancer	0.000788	0.00373	CcSEcCtD
Benazepril—Shock—Imiquimod—skin cancer	0.000787	0.00372	CcSEcCtD
Benazepril—Pollakiuria—Temozolomide—skin cancer	0.000779	0.00368	CcSEcCtD
Benazepril—Erectile dysfunction—Temozolomide—skin cancer	0.000776	0.00367	CcSEcCtD
Benazepril—Agranulocytosis—Dactinomycin—skin cancer	0.000775	0.00367	CcSEcCtD
Benazepril—Hyperhidrosis—Imiquimod—skin cancer	0.000773	0.00366	CcSEcCtD
Benazepril—Photosensitivity reaction—Temozolomide—skin cancer	0.000769	0.00364	CcSEcCtD
Benazepril—Eosinophilia—Fluorouracil—skin cancer	0.000769	0.00364	CcSEcCtD
Benazepril—Angina pectoris—Fluorouracil—skin cancer	0.000756	0.00358	CcSEcCtD
Benazepril—Hepatitis—Dactinomycin—skin cancer	0.000746	0.00353	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000745	0.00352	CcSEcCtD
Benazepril—Flushing—Bleomycin—skin cancer	0.000742	0.00351	CcSEcCtD
Benazepril—Pharyngitis—Dactinomycin—skin cancer	0.00074	0.0035	CcSEcCtD
Benazepril—Urinary tract infection—Temozolomide—skin cancer	0.00073	0.00345	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000729	0.00345	CcSEcCtD
Benazepril—Insomnia—Imiquimod—skin cancer	0.000723	0.00342	CcSEcCtD
Benazepril—Paraesthesia—Imiquimod—skin cancer	0.000718	0.0034	CcSEcCtD
Benazepril—Dyspnoea—Imiquimod—skin cancer	0.000713	0.00337	CcSEcCtD
Benazepril—Somnolence—Imiquimod—skin cancer	0.000711	0.00336	CcSEcCtD
Benazepril—Photosensitivity reaction—Fluorouracil—skin cancer	0.000709	0.00335	CcSEcCtD
Benazepril—Alopecia—Bleomycin—skin cancer	0.000707	0.00334	CcSEcCtD
Benazepril—Erythema multiforme—Dactinomycin—skin cancer	0.000705	0.00334	CcSEcCtD
Benazepril—Sinusitis—Temozolomide—skin cancer	0.000705	0.00333	CcSEcCtD
Benazepril—Dyspepsia—Imiquimod—skin cancer	0.000704	0.00333	CcSEcCtD
Benazepril—Flushing—Dactinomycin—skin cancer	0.000692	0.00327	CcSEcCtD
Benazepril—Hypersensitivity—Vemurafenib—skin cancer	0.000691	0.00327	CcSEcCtD
Benazepril—Fatigue—Imiquimod—skin cancer	0.00069	0.00326	CcSEcCtD
Benazepril—Acute coronary syndrome—Fluorouracil—skin cancer	0.000683	0.00323	CcSEcCtD
Benazepril—Myocardial infarction—Fluorouracil—skin cancer	0.000679	0.00321	CcSEcCtD
Benazepril—Hepatitis—Temozolomide—skin cancer	0.000675	0.00319	CcSEcCtD
Benazepril—Urinary tract infection—Fluorouracil—skin cancer	0.000673	0.00318	CcSEcCtD
Benazepril—Asthenia—Vemurafenib—skin cancer	0.000673	0.00318	CcSEcCtD
Benazepril—Pharyngitis—Temozolomide—skin cancer	0.00067	0.00317	CcSEcCtD
Benazepril—Oedema peripheral—Temozolomide—skin cancer	0.000665	0.00314	CcSEcCtD
Benazepril—Pruritus—Vemurafenib—skin cancer	0.000664	0.00314	CcSEcCtD
Benazepril—Alopecia—Dactinomycin—skin cancer	0.000659	0.00312	CcSEcCtD
Benazepril—Gastrointestinal pain—Imiquimod—skin cancer	0.000654	0.00309	CcSEcCtD
Benazepril—Hyponatraemia—Docetaxel—skin cancer	0.000651	0.00308	CcSEcCtD
Benazepril—Sinusitis—Fluorouracil—skin cancer	0.00065	0.00307	CcSEcCtD
Benazepril—Agranulocytosis—Fluorouracil—skin cancer	0.000646	0.00306	CcSEcCtD
Benazepril—Diarrhoea—Vemurafenib—skin cancer	0.000642	0.00303	CcSEcCtD
Benazepril—Erythema multiforme—Temozolomide—skin cancer	0.000638	0.00302	CcSEcCtD
Benazepril—Abdominal pain—Imiquimod—skin cancer	0.000632	0.00299	CcSEcCtD
Benazepril—Tinnitus—Temozolomide—skin cancer	0.000629	0.00297	CcSEcCtD
Benazepril—Flushing—Temozolomide—skin cancer	0.000626	0.00296	CcSEcCtD
Benazepril—Leukopenia—Bleomycin—skin cancer	0.000623	0.00295	CcSEcCtD
Benazepril—Rhinitis—Fluorouracil—skin cancer	0.000623	0.00295	CcSEcCtD
Benazepril—Dizziness—Vemurafenib—skin cancer	0.00062	0.00293	CcSEcCtD
Benazepril—Pharyngitis—Fluorouracil—skin cancer	0.000617	0.00292	CcSEcCtD
Benazepril—Cough—Bleomycin—skin cancer	0.000608	0.00287	CcSEcCtD
Benazepril—Vomiting—Vemurafenib—skin cancer	0.000596	0.00282	CcSEcCtD
Benazepril—Alopecia—Temozolomide—skin cancer	0.000596	0.00282	CcSEcCtD
Benazepril—Chest pain—Bleomycin—skin cancer	0.000593	0.0028	CcSEcCtD
Benazepril—Myalgia—Bleomycin—skin cancer	0.000593	0.0028	CcSEcCtD
Benazepril—Orthostatic hypotension—Docetaxel—skin cancer	0.000592	0.0028	CcSEcCtD
Benazepril—Rash—Vemurafenib—skin cancer	0.000591	0.0028	CcSEcCtD
Benazepril—Dermatitis—Vemurafenib—skin cancer	0.000591	0.00279	CcSEcCtD
Benazepril—Hypersensitivity—Imiquimod—skin cancer	0.000589	0.00279	CcSEcCtD
Benazepril—Headache—Vemurafenib—skin cancer	0.000588	0.00278	CcSEcCtD
Benazepril—Leukopenia—Dactinomycin—skin cancer	0.000581	0.00275	CcSEcCtD
Benazepril—Asthenia—Imiquimod—skin cancer	0.000574	0.00271	CcSEcCtD
Benazepril—Anaphylactic shock—Bleomycin—skin cancer	0.000568	0.00269	CcSEcCtD
Benazepril—Oedema—Bleomycin—skin cancer	0.000568	0.00269	CcSEcCtD
Benazepril—Back pain—Temozolomide—skin cancer	0.000568	0.00269	CcSEcCtD
Benazepril—Pruritus—Imiquimod—skin cancer	0.000566	0.00268	CcSEcCtD
Benazepril—Infection—Bleomycin—skin cancer	0.000564	0.00267	CcSEcCtD
Benazepril—Nausea—Vemurafenib—skin cancer	0.000557	0.00263	CcSEcCtD
Benazepril—Thrombocytopenia—Bleomycin—skin cancer	0.000556	0.00263	CcSEcCtD
Benazepril—Arrhythmia—Fluorouracil—skin cancer	0.000555	0.00263	CcSEcCtD
Benazepril—Myalgia—Dactinomycin—skin cancer	0.000553	0.00261	CcSEcCtD
Benazepril—Alopecia—Fluorouracil—skin cancer	0.000549	0.0026	CcSEcCtD
Benazepril—Diarrhoea—Imiquimod—skin cancer	0.000547	0.00259	CcSEcCtD
Benazepril—Angina pectoris—Docetaxel—skin cancer	0.000546	0.00258	CcSEcCtD
Benazepril—Angioedema—Temozolomide—skin cancer	0.000537	0.00254	CcSEcCtD
Benazepril—Hypotension—Bleomycin—skin cancer	0.000531	0.00251	CcSEcCtD
Benazepril—Oedema—Dactinomycin—skin cancer	0.00053	0.00251	CcSEcCtD
Benazepril—Dizziness—Imiquimod—skin cancer	0.000529	0.0025	CcSEcCtD
Benazepril—Vertigo—Temozolomide—skin cancer	0.000528	0.0025	CcSEcCtD
Benazepril—Infection—Dactinomycin—skin cancer	0.000526	0.00249	CcSEcCtD
Benazepril—Leukopenia—Temozolomide—skin cancer	0.000526	0.00249	CcSEcCtD
Benazepril—Neutropenia—Docetaxel—skin cancer	0.000524	0.00248	CcSEcCtD
Benazepril—Palpitations—Temozolomide—skin cancer	0.000519	0.00245	CcSEcCtD
Benazepril—Thrombocytopenia—Dactinomycin—skin cancer	0.000519	0.00245	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000518	0.00245	CcSEcCtD
Benazepril—Cough—Temozolomide—skin cancer	0.000512	0.00242	CcSEcCtD
Benazepril—Paraesthesia—Bleomycin—skin cancer	0.00051	0.00241	CcSEcCtD
Benazepril—Vomiting—Imiquimod—skin cancer	0.000509	0.0024	CcSEcCtD
Benazepril—Dyspnoea—Bleomycin—skin cancer	0.000507	0.0024	CcSEcCtD
Benazepril—Rash—Imiquimod—skin cancer	0.000504	0.00238	CcSEcCtD
Benazepril—Dermatitis—Imiquimod—skin cancer	0.000504	0.00238	CcSEcCtD
Benazepril—Headache—Imiquimod—skin cancer	0.000501	0.00237	CcSEcCtD
Benazepril—Arthralgia—Temozolomide—skin cancer	0.0005	0.00236	CcSEcCtD
Benazepril—Myalgia—Temozolomide—skin cancer	0.0005	0.00236	CcSEcCtD
Benazepril—Anxiety—Temozolomide—skin cancer	0.000498	0.00236	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000495	0.00234	CcSEcCtD
Benazepril—Acute coronary syndrome—Docetaxel—skin cancer	0.000493	0.00233	CcSEcCtD
Benazepril—Myocardial infarction—Docetaxel—skin cancer	0.00049	0.00232	CcSEcCtD
Benazepril—Leukopenia—Fluorouracil—skin cancer	0.000484	0.00229	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000483	0.00228	CcSEcCtD
Benazepril—Oedema—Temozolomide—skin cancer	0.000479	0.00227	CcSEcCtD
Benazepril—Anaphylactic shock—Temozolomide—skin cancer	0.000479	0.00227	CcSEcCtD
Benazepril—Infection—Temozolomide—skin cancer	0.000476	0.00225	CcSEcCtD
Benazepril—Nausea—Imiquimod—skin cancer	0.000475	0.00225	CcSEcCtD
Benazepril—Thrombocytopenia—Temozolomide—skin cancer	0.000469	0.00222	CcSEcCtD
Benazepril—Agranulocytosis—Docetaxel—skin cancer	0.000466	0.00221	CcSEcCtD
Benazepril—Hyperhidrosis—Temozolomide—skin cancer	0.000463	0.00219	CcSEcCtD
Benazepril—Myalgia—Fluorouracil—skin cancer	0.000461	0.00218	CcSEcCtD
Benazepril—Chest pain—Fluorouracil—skin cancer	0.000461	0.00218	CcSEcCtD
Benazepril—Fatigue—Dactinomycin—skin cancer	0.000457	0.00216	CcSEcCtD
Benazepril—Rhinitis—Docetaxel—skin cancer	0.00045	0.00213	CcSEcCtD
Benazepril—Hepatitis—Docetaxel—skin cancer	0.000449	0.00212	CcSEcCtD
Benazepril—Pharyngitis—Docetaxel—skin cancer	0.000445	0.00211	CcSEcCtD
Benazepril—Oedema peripheral—Docetaxel—skin cancer	0.000442	0.00209	CcSEcCtD
Benazepril—Oedema—Fluorouracil—skin cancer	0.000442	0.00209	CcSEcCtD
Benazepril—Anaphylactic shock—Fluorouracil—skin cancer	0.000442	0.00209	CcSEcCtD
Benazepril—Infection—Fluorouracil—skin cancer	0.000439	0.00207	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000437	0.00207	CcSEcCtD
Benazepril—Insomnia—Temozolomide—skin cancer	0.000434	0.00205	CcSEcCtD
Benazepril—Gastrointestinal pain—Dactinomycin—skin cancer	0.000433	0.00205	CcSEcCtD
Benazepril—Thrombocytopenia—Fluorouracil—skin cancer	0.000432	0.00204	CcSEcCtD
Benazepril—Paraesthesia—Temozolomide—skin cancer	0.00043	0.00204	CcSEcCtD
Benazepril—Dyspnoea—Temozolomide—skin cancer	0.000427	0.00202	CcSEcCtD
Benazepril—Somnolence—Temozolomide—skin cancer	0.000426	0.00201	CcSEcCtD
Benazepril—Erythema multiforme—Docetaxel—skin cancer	0.000424	0.00201	CcSEcCtD
Benazepril—Dyspepsia—Temozolomide—skin cancer	0.000422	0.002	CcSEcCtD
Benazepril—Abdominal pain—Dactinomycin—skin cancer	0.000419	0.00198	CcSEcCtD
Benazepril—Hypersensitivity—Bleomycin—skin cancer	0.000419	0.00198	CcSEcCtD
Benazepril—Flushing—Docetaxel—skin cancer	0.000416	0.00197	CcSEcCtD
Benazepril—Fatigue—Temozolomide—skin cancer	0.000413	0.00195	CcSEcCtD
Benazepril—Hypotension—Fluorouracil—skin cancer	0.000413	0.00195	CcSEcCtD
Benazepril—Constipation—Temozolomide—skin cancer	0.00041	0.00194	CcSEcCtD
Benazepril—Asthenia—Bleomycin—skin cancer	0.000408	0.00193	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000402	0.0019	CcSEcCtD
Benazepril—Pruritus—Bleomycin—skin cancer	0.000402	0.0019	CcSEcCtD
Benazepril—Arrhythmia—Docetaxel—skin cancer	0.000401	0.0019	CcSEcCtD
Benazepril—Insomnia—Fluorouracil—skin cancer	0.000399	0.00189	CcSEcCtD
Benazepril—Paraesthesia—Fluorouracil—skin cancer	0.000397	0.00188	CcSEcCtD
Benazepril—Alopecia—Docetaxel—skin cancer	0.000396	0.00187	CcSEcCtD
Benazepril—Dyspnoea—Fluorouracil—skin cancer	0.000394	0.00186	CcSEcCtD
Benazepril—Somnolence—Fluorouracil—skin cancer	0.000393	0.00186	CcSEcCtD
Benazepril—Gastrointestinal pain—Temozolomide—skin cancer	0.000392	0.00185	CcSEcCtD
Benazepril—Hypersensitivity—Dactinomycin—skin cancer	0.00039	0.00185	CcSEcCtD
Benazepril—Dyspepsia—Fluorouracil—skin cancer	0.000389	0.00184	CcSEcCtD
Benazepril—Asthenia—Dactinomycin—skin cancer	0.00038	0.0018	CcSEcCtD
Benazepril—Abdominal pain—Temozolomide—skin cancer	0.000379	0.00179	CcSEcCtD
Benazepril—Back pain—Docetaxel—skin cancer	0.000378	0.00179	CcSEcCtD
Benazepril—Diarrhoea—Dactinomycin—skin cancer	0.000363	0.00171	CcSEcCtD
Benazepril—Vomiting—Bleomycin—skin cancer	0.000361	0.00171	CcSEcCtD
Benazepril—Rash—Bleomycin—skin cancer	0.000358	0.00169	CcSEcCtD
Benazepril—Dermatitis—Bleomycin—skin cancer	0.000358	0.00169	CcSEcCtD
Benazepril—Hypersensitivity—Temozolomide—skin cancer	0.000353	0.00167	CcSEcCtD
Benazepril—Syncope—Docetaxel—skin cancer	0.00035	0.00166	CcSEcCtD
Benazepril—Leukopenia—Docetaxel—skin cancer	0.00035	0.00165	CcSEcCtD
Benazepril—Palpitations—Docetaxel—skin cancer	0.000345	0.00163	CcSEcCtD
Benazepril—Asthenia—Temozolomide—skin cancer	0.000344	0.00163	CcSEcCtD
Benazepril—Loss of consciousness—Docetaxel—skin cancer	0.000343	0.00162	CcSEcCtD
Benazepril—Cough—Docetaxel—skin cancer	0.000341	0.00161	CcSEcCtD
Benazepril—Pruritus—Temozolomide—skin cancer	0.000339	0.0016	CcSEcCtD
Benazepril—Nausea—Bleomycin—skin cancer	0.000338	0.0016	CcSEcCtD
Benazepril—Vomiting—Dactinomycin—skin cancer	0.000337	0.00159	CcSEcCtD
Benazepril—Rash—Dactinomycin—skin cancer	0.000334	0.00158	CcSEcCtD
Benazepril—Arthralgia—Docetaxel—skin cancer	0.000332	0.00157	CcSEcCtD
Benazepril—Chest pain—Docetaxel—skin cancer	0.000332	0.00157	CcSEcCtD
Benazepril—Myalgia—Docetaxel—skin cancer	0.000332	0.00157	CcSEcCtD
Benazepril—Diarrhoea—Temozolomide—skin cancer	0.000328	0.00155	CcSEcCtD
Benazepril—Hypersensitivity—Fluorouracil—skin cancer	0.000325	0.00154	CcSEcCtD
Benazepril—Oedema—Docetaxel—skin cancer	0.000319	0.00151	CcSEcCtD
Benazepril—Anaphylactic shock—Docetaxel—skin cancer	0.000319	0.00151	CcSEcCtD
Benazepril—Dizziness—Temozolomide—skin cancer	0.000317	0.0015	CcSEcCtD
Benazepril—Infection—Docetaxel—skin cancer	0.000317	0.0015	CcSEcCtD
Benazepril—Nausea—Dactinomycin—skin cancer	0.000315	0.00149	CcSEcCtD
Benazepril—Shock—Docetaxel—skin cancer	0.000314	0.00148	CcSEcCtD
Benazepril—Pruritus—Fluorouracil—skin cancer	0.000312	0.00148	CcSEcCtD
Benazepril—Thrombocytopenia—Docetaxel—skin cancer	0.000312	0.00148	CcSEcCtD
Benazepril—Vomiting—Temozolomide—skin cancer	0.000305	0.00144	CcSEcCtD
Benazepril—Rash—Temozolomide—skin cancer	0.000302	0.00143	CcSEcCtD
Benazepril—Diarrhoea—Fluorouracil—skin cancer	0.000302	0.00143	CcSEcCtD
Benazepril—Dermatitis—Temozolomide—skin cancer	0.000302	0.00143	CcSEcCtD
Benazepril—Headache—Temozolomide—skin cancer	0.0003	0.00142	CcSEcCtD
Benazepril—Hypotension—Docetaxel—skin cancer	0.000298	0.00141	CcSEcCtD
Benazepril—Dizziness—Fluorouracil—skin cancer	0.000292	0.00138	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00029	0.00137	CcSEcCtD
Benazepril—Insomnia—Docetaxel—skin cancer	0.000288	0.00136	CcSEcCtD
Benazepril—Paraesthesia—Docetaxel—skin cancer	0.000286	0.00135	CcSEcCtD
Benazepril—Nausea—Temozolomide—skin cancer	0.000285	0.00135	CcSEcCtD
Benazepril—Dyspnoea—Docetaxel—skin cancer	0.000284	0.00134	CcSEcCtD
Benazepril—Somnolence—Docetaxel—skin cancer	0.000283	0.00134	CcSEcCtD
Benazepril—Vomiting—Fluorouracil—skin cancer	0.000281	0.00133	CcSEcCtD
Benazepril—Dyspepsia—Docetaxel—skin cancer	0.000281	0.00133	CcSEcCtD
Benazepril—Rash—Fluorouracil—skin cancer	0.000278	0.00132	CcSEcCtD
Benazepril—Dermatitis—Fluorouracil—skin cancer	0.000278	0.00132	CcSEcCtD
Benazepril—Headache—Fluorouracil—skin cancer	0.000277	0.00131	CcSEcCtD
Benazepril—Fatigue—Docetaxel—skin cancer	0.000275	0.0013	CcSEcCtD
Benazepril—Constipation—Docetaxel—skin cancer	0.000273	0.00129	CcSEcCtD
Benazepril—Nausea—Fluorouracil—skin cancer	0.000262	0.00124	CcSEcCtD
Benazepril—Gastrointestinal pain—Docetaxel—skin cancer	0.000261	0.00123	CcSEcCtD
Benazepril—Abdominal pain—Docetaxel—skin cancer	0.000252	0.00119	CcSEcCtD
Benazepril—Hypersensitivity—Docetaxel—skin cancer	0.000235	0.00111	CcSEcCtD
Benazepril—Asthenia—Docetaxel—skin cancer	0.000229	0.00108	CcSEcCtD
Benazepril—Pruritus—Docetaxel—skin cancer	0.000226	0.00107	CcSEcCtD
Benazepril—Diarrhoea—Docetaxel—skin cancer	0.000218	0.00103	CcSEcCtD
Benazepril—Dizziness—Docetaxel—skin cancer	0.000211	0.000997	CcSEcCtD
Benazepril—Vomiting—Docetaxel—skin cancer	0.000203	0.000958	CcSEcCtD
Benazepril—Rash—Docetaxel—skin cancer	0.000201	0.00095	CcSEcCtD
Benazepril—Dermatitis—Docetaxel—skin cancer	0.000201	0.00095	CcSEcCtD
Benazepril—Headache—Docetaxel—skin cancer	0.0002	0.000944	CcSEcCtD
Benazepril—Nausea—Docetaxel—skin cancer	0.000189	0.000895	CcSEcCtD
